3D Cell Culture Market Projected to Reach Valuation of USD 2,051.5 Million by 2028

Vantage Market Research

Feb 24, 2022

In terms of revenue, the Global 3D Cell Culture Market is expected to reach USD 2,051.5 Million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 15.1% from 2022 to 2028. Increasing focus on personalized medicine, rising awareness on developing alternatives to animal testing, large funding towards research activities, and rising occurrences of chronic diseases are some of the major factors that propelling the growth of 3D Cell Culture Market in upcoming years.

Key Findings:

  • Cancer & stem cell research application segment is accounted to mention the substantial growth of 3D Cell Culture Market in 2021. This growth is mainly accounted to the increasing funding activities for cancer research and the rising prevalence of cancer.
  • Scaffold-based 3D cell cultures sub-segment of product segment is incorporated potential growth of 3D Cell Culture Market in 2021. This growth is prominently driven owing to the availability of vast features of scaffolds in 3D cell culture such as the availability of attachment points and structural rigidity.
  • North America is incorporated to witness the largest share of the 3D Cell Culture Market during the forecast period. The recent commercialization of microfluidics-based products, increasing research activities, increasing pharmaceutical & biotechnology industry and large presence of major market players are accelerating the growth of 3D Cell Culture Market in this region.

Some of key players in 3D Cell Culture Market include - Thermo Fisher Scientific (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza Group AG (Switzerland), Avantor Inc. (US), Tecan Trading AG (Switzerland), 3D Biotek LLC (US), REPROCELL Inc. (Japan), Kirkstall Ltd (UK), MIMETAS BV (Netherlands), PromoCell GmbH (Germany), Emulate Inc. (US), CN Bio Innovations (UK), InSphero AG (Switzerland), Greiner Bio-One International GmbH (Austria), TissUse GmbH (Germany).

The organoid models are used to develop small tissue samples with the help of stem cells. Thus, this model is expected to influence the huge demand for 3D cell culture technology in the market. For example, organ-on-a-chip technology is used to monitor the effects of drugs on the body. Thus, this technology allows scientists to analyze cardiac cells cultures for electrical activity in real-time. Organoid models are widely used to develop a variety of cell types from harvested stem cells. Therefore, usage of these models in the medical industry creates various opportunities to grow 3D Cell Culture Market in near future.

Asia Pacific accounted the fastest-growing region for 3D Cell Culture Market in 2021. The various pharmaceutical and biotechnology companies use 3D culture technology in this region. This is one of the key factors that augment the growth of the 3D Cell Culture Market in this region. In addition, the large presence of clinical laboratories & research institutes for drug discovery and producing regenerative medicines is further fuelling the market growth in this region. Furthermore, rising cancer cases increases the government focus to provide research funding for cancer drug discovery, thus, propelling the growth of 3D Cell Culture Market in this region.